Economy
Latest News
Finland to Audit US NATO Weapon Deliveries
The latest report underscores growing concern within NATO itself over whether weapons intended for Ukraine are actually reaching their destination, as Finland has now
Virginia Permits ADULT MIGRANT MEN to Attend High School
Virginia is allowing 22-year-old grown men, illegal migrants who don’t speak English, to enroll in public high school with your 14- and 15-year-old daughters. Mind
Iran Introduces 10 Million Rial Banknote
What Iran is doing right now is something we have seen repeatedly throughout history whenever a currency begins to die. Governments start issuing larger and
Politic
Business
Health
How to Help Your Knee Recover After a Major Twist
Twisting a knee can be a scary moment. One second everything feels normal, and the next there is a sharp pain, a strange wobble, or
Why Some Mothers Still Look Pregnant After Having a Baby
Becoming a mother is one of life’s most beautiful experiences, yet for many women, the weeks and months after childbirth bring an unexpected challenge. They
The Importance of Consistency and Support in Addiction Recovery
Recovery from addiction is a deeply personal journey, yet it is also one that thrives on structure, guidance, and connection. While the decision to seek
The Healing Benefits of Raw Honey for Cuts, Burns, and Sore Throats
For centuries, raw honey has been revered not just as a natural sweetener but as a potent medicinal agent. Stored in the pantries of traditional
Innovation
Environment
Markets
Hims & Hers Health, Inc. (HIMS) Jumps 8.6% to $20.41
HIMS Price $20.41 Change +8.6% Volume 16.9M Hims & Hers Health, Inc. surged 8.6% to $20.41 on Tuesday as a broad rally lifted sector peers
BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap
BKYI|EPS -$0.19|Rev $1.2M|Net Loss $1.7M Stock $0.51 (-13%) Losses Narrow Substantially. BIO-key International, Inc. (NASDAQ:BKYI) posted a loss per share of -$0.19 for Q4 2025,
Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87
ARWR Price $61.87 Change +7.3% Volume 723,156 Arrowhead Pharmaceuticals surged 7.3% to $61.87 on Tuesday as a broad rally lifted biotechnology stocks across the sector.
FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap
FDS|EPS $4.46|Rev $611.0M|Net Income $133.1M Guidance adjusted $17.25 – $17.75|Stock $290.37 (+2.3%) Solid Quarter Delivered. FactSet Research Systems Inc. (NYSE: FDS) reported Q2 2026 adjusted